Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.
Spun out of the University of Oxford, Yellowstone is built around the pioneering research of Professor Paresh Vyas, a world-renowned scientific academic, key opinion leader and practising clinician with a specialist focus on acute myeloid leukaemia (AML).
The Company is headquartered in Oxford, UK, with backing from a leading FTSE 250 healthcare company, Syncona.
Company Details
- Employees
- 26
- Founded
- 2024
- Address
- Oxford, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://yellowstonebio.com/
- Keywords
- Syncona Limited.
- HQ
- Oxford
Yellowstone Biosciences Questions
Yellowstone Biosciences's website is https://yellowstonebio.com/
Yellowstone Biosciences's LinkedIn profile is https://uk.linkedin.com/company/yellowstone-biosciences
Yellowstone Biosciences has
26 employees.
View email and phone details for 26
employees at Yellowstone Biosciences.
Yellowstone Biosciences's industry is
Biotechnology Research
Yellowstone Biosciences's top competitors are
Immunocore,
Resolution Therapeutics,
Bloomsbury Genetic Therapies,
Akamis Bio,
Syncona Limited,
Hlx Life Sciences,
Oxb,
Forcefield Therapeutics,
Relation,
Myricx Bio.
Yellowstone Biosciences's categories are Biotechnology Research
Yellowstone Biosciences's founding year is 2024
